Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleic acids, comprising deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), are the fundamental molecules responsible for the storage, transmission, and expression of genetic information in all living organisms (National Human Genome Research Institute, 2023). DNA serves as the long-term repository of the genome, while various RNA species, including mRNA, tRNA, and rRNA, facilitate the translation of genetic code into functional proteins and provide regulatory control over cellular processes (Nature Education, 2014). In clinical practice, DNA has historically been a primary target for cytotoxic chemotherapies, such as alkylating agents and platinum-based drugs, which induce structural damage to halt the proliferation of malignant cells (PubMed, PMID: 28331195). More recently, RNA has emerged as a versatile therapeutic target through the development of antisense oligonucleotides and RNA interference (RNAi) technologies, which allow for the highly specific silencing of disease-associated genes or the correction of aberrant splicing (Nature Reviews Drug Discovery, 2020). Targeting nucleic acids is a cornerstone of treatment for oncology, viral infections, and rare genetic disorders, though it necessitates careful management of risks such as genotoxicity and off-target immune stimulation (PubMed, PMID: 31558516).
Therapeutic strategies targeting nucleic acids include DNA alkylation and covalent cross-linking to induce apoptosis (StatPearls, 2023), intercalation to inhibit replication and transcription, and the use of sequence-specific antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) to degrade target mRNA or modulate splicing patterns (Nature Reviews Drug Discovery, 2020).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic acids (DNA and RNA) (DNA/RNA).